Esophageal surgical Apgar score (eSAS): A predictor for postoperative morbidity in patients undergoing neoadjuvant therapy and esophagectomy

Author:

Wang Qin1,Zhang Chi1,Qi Chen1,Qiang Yong2,Zhang Zheng3,Xu Fei3,Shen Yi1ORCID

Affiliation:

1. Department of Cardiothoracic Surgery, Jinling Hospital Medical School of Nanjing University Nanjing China

2. Department of Cardiothoracic Surgery, Jinling Hospital, School of Medicine Southeast University Nanjing China

3. Department of Cardiothoracic Surgery, Jinling Hospital, School of Clinical Medicine Nanjing Medical University Nanjing China

Abstract

AbstractBackgroundThe surgical Apgar score (SAS) quantifying three intraoperative indexes has been confirmed to be significantly associated with postoperative morbidity and prognosis in many surgical specialties. However, there are great limitations in its application for esophageal cancer (EC). This study aimed to assess the predictive capability of esophagectomy SAS (eSAS) in determining postoperative morbidity and overall survival (OS) in EC patients who had undergone neoadjuvant therapy.MethodsA retrospective evaluation was conducted on a cohort of 221 patients in which surgery‐ and tumor‐related data were extracted and analyzed. Major morbidity was defined as complications meeting the criteria of Clavien‐Dindo classification III or higher during hospitalization. Univariate and multivariate analyses were performed to identify potential risk factors for major morbidity. Kaplan–Meier analysis was utilized to calculate the OS and relapse‐free survival (RFS).ResultsThe results exhibited that eSAS demonstrated potential predictive value for postoperative morbidity with an optimal cutoff value of 6. The eSAS and diabetes mellitus were two independent risk factors for the major morbidity; however, no correlation between the eSAS and the OS or RFS was detected.ConclusionThe eSAS could be used as a predictor of major morbidity, while it was not correlated with OS and RFS.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3